The GROWTH consortium, funded by the European Commission (2019-2023), is made up to train a new generation of researchers working on new pathological insights, biomarker diagnostics and personalized nutritional interventions for intestinal failure in neonates and preterm infants.
Academic and industry partners, covering various disciplines ranging from fundamental research to clinical paediatrics and analytical chemistry to organoid and gut-on-chip applications, have teamed up in the European Union.
GROWTH aims to set-up a new European platform that trains young scientists in the industry-led exploration of innovative routes to fully exploit the potential of early life nutrition to prevent inflammatory disease. GROWTH coordinates 8 individual research projects.
If you have any questions you can fill in the form or mail us directly: email@example.com.
The group at the Tytgat Institute for Liver and Intestinal Research in Amsterdam, headed by Prof. Dr. Wouter de Jonge and partner in the GROWTH network recently acquired a large 2.5 milion research grant for the exploration of new therapies for Crohn’s Disease.
Scientific discovery needs diverse perspectives in order to achieve innovative results at the highest level. Appropriate consideration of women or members of underrepresented groups in science at all levels broadens perspectives and opinions and thus contributes to outstanding research.
Life2021, the NWO conference for the Dutch Life Sciences will be a digital conference. Save the afternoons of 26, 27 and 28 May.
A comprehensive analysis of the fecal microbiota and metabolome during a course of EEN therapy in paediatric patients with Crohn's Disease was conducted by the AMC (Tytgat Institute) research groups led by Dr. Jurgen Seppen and Prof. Wouter de Jonge.